Literature DB >> 24295494

miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status.

W Li, F Guo, P Wang, S Hong, C Zhang1.   

Abstract

Glioblastoma is highly resistant to radiation therapy. The underlying molecular mechanism is not completely understood. The DNA damage response (DDR) pathway plays a crucial role in radioresistance of glioablastoma cells. Growing evidence has demonstrated that radiation induces alterations in microRNA (miR) profiles. However, how radiation induces specific miRs and how they might regulate the DDR remain elusive. In our study, we found that radiation induced c-jun transcription of miR-221 and miR-222. miR-221 and miR- 222 modulated DNA-PKcs expression to affect DNA damage repair by activating Akt independent of PTEN status. Knocking down of miR-221/222 significantly increased radiosensitivity of glioblastoma cells. Inhibition of Akt by RNAi or LY294002 treatment may overcome miR-221/222 induced radioresistance. Notably, combined anti-miR-221/222 and radiotherapy has remarkably inhibited tumor growth compared with anti-miR-221/222 or radiotherapy alone in a subcutaneous mouse model. Our results suggest that radio-induced c-jun promotes transcription of miR-221/222, which mediates DNA damage repair of glioblastoma cells independent of PTEN. These data indicate for the first time that miR-221/222 play an important role in mediating radio-induced DNA damage repair and that miR-221/222 could serve as potential therapeutic targets for increasing radiosensitivity of glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24295494     DOI: 10.2174/1566524013666131203103147

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  31 in total

1.  Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.

Authors:  Juliana I Santos; Ana L Teixeira; Francisca Dias; Joaquina Maurício; Francisco Lobo; António Morais; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-24

2.  MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.

Authors:  Yong Shang; Li-Qing Wang; Quan-Yi Guo; Tu-Long Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  A functional screen identifies miRs that induce radioresistance in glioblastomas.

Authors:  Patryk Moskwa; Pascal O Zinn; Young Eun Choi; Sachet A Shukla; Wojciech Fendler; Clark C Chen; Jun Lu; Todd R Golub; Anita Hjelmeland; Dipanjan Chowdhury
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

4.  Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines.

Authors:  Emanuela Mari; Alessandra Zicari; Flavia Fico; Isabella Massimi; Lolli Martina; Stefania Mardente
Journal:  Oncol Lett       Date:  2016-07-18       Impact factor: 2.967

5.  MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.

Authors:  Long Chen; Wenhua Wang; Shengqiang Zhu; Xuegang Jin; Jian Wang; Jianfang Zhu; Youxin Zhou
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

6.  Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.

Authors:  Takatoshi Tokudome; Akiko Sasaki; Mayumi Tsuji; Yuko Udaka; Hideto Oyamada; Hiromichi Tsuchiya; Katsuji Oguchi
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

7.  Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.

Authors:  Xinxing Li; Jihui Zheng; Liangyu Chen; Hongyu Diao; Yunhui Liu
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

8.  A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

Authors:  Annamaria Gullà; Maria Teresa Di Martino; Maria Eugenia Gallo Cantafio; Eugenio Morelli; Nicola Amodio; Cirino Botta; Maria Rita Pitari; Santo Giovanni Lio; Domenico Britti; Maria Angelica Stamato; Teru Hideshima; Nikhil C Munshi; Kenneth C Anderson; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Clin Cancer Res       Date:  2015-11-02       Impact factor: 12.531

Review 9.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

10.  Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation.

Authors:  Fujio Suzuki; Bradford D Loucas; Ichiaki Ito; Akira Asai; Sumihiro Suzuki; Makiko Kobayashi
Journal:  J Immunol       Date:  2018-05-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.